InsiderTrades

Form 4 for ALT Altimmune, Inc.

Accepted 2024-02-01 00:00:00 ET · period of report 2024-01-30 · accession 0001104659-24-009539 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-01 2024-01-31 ALT Garg Vipin K Pres, CEO, Dir A - Grant $2.69 +7,889 272.2K +3% +$21.2K
D 2024-02-01 2024-01-30 ALT Garg Vipin K Pres, CEO, Dir F - Tax $9.80 -11.7K 264.3K -4% -$114.6K
D 2024-02-01 2024-01-30 ALT Garg Vipin K Pres, CEO, Dir M - OptEx $0.00 +26.8K 276.0K +11% $0
D 2024-02-01 2024-01-30 ALT Garg Vipin K Pres, CEO, Dir M - OptEx $0.00 -26.8K 80.3K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.0001 2024-01-31 A A 7,889 $2.69 272,222 D — — (F4) In accordance with the ESPP, these shares were purchased based on 85% of the opening price of the issuer's common stock on August 1, 2023.
2 Common Common Stock, par value $0.0001 2024-01-30 F D 11,697 $9.80 264,333 D — —
3 Common Common Stock, par value $0.0001 2024-01-30 M A 26,775 $0.00 276,030 D — — (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
4 Derivative Restricted Stock Units 2024-01-30 M D 26,775 $0.00 80,325 D — · — to — 26,775 Common Stock, par value $0.0001 (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. (F5) The RSUs become vested in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.